The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bacteria-specific CXCL13-producing follicular helper T cells are putative prognostic markers to neoadjuvant PD-1 blockade in muscle-invasive urothelial carcinoma.
 
Anne-Gaëlle Goubet
Employment - Debiopharm Group (I)
 
Carolina Alves Costa Silva
No Relationships to Disclose
 
Leonardo Lordello De Melo
No Relationships to Disclose
 
Marianne Gazzano
No Relationships to Disclose
 
Cédric Lebacle
Honoraria - Bayer; Bouchara Recordati; Ipsen
Research Funding - Astellas Amgen BioPharama
 
Constance Thibault
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Merck; Pfizer; Sanofi
Research Funding - AstraZeneca; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Merck; Mylan; Sanofi
 
Geraldine Pignot
Honoraria - Astellas Pharma; Bouchara Recordati; Bristol-Myers Squibb/Pfizer; Ipsen; Janssen-Cilag; Roche
Consulting or Advisory Role - Janssen-Cilag; MSD Oncology (Inst); Pfizer; Roche
Expert Testimony - Astellas Pharma; Bouchara Recordati; Janssen
Travel, Accommodations, Expenses - Astellas Pharma; Ferring; Ipsen; Janssen-Cilag; Pfizer
 
Carole Helissey
Honoraria - Astellas Amgen BioPharama; AstraZeneca; Bayer; Janssen; Roche; Sanofi
 
Morgan Roupret
Consulting or Advisory Role - Arquer Diagnostics; GlaxoSmithKline; Intuitive Surgical; Ipsen; Janssen-Cilag; Lilly; MSD; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Coloplast
 
Evanguelos Xylinas
No Relationships to Disclose
 
Caroline Flament
No Relationships to Disclose
 
Virginie Marty
No Relationships to Disclose
 
Nicolas Signolle
No Relationships to Disclose
 
Baptiste Archambaud
No Relationships to Disclose
 
Shayma Bel-Hechmi
No Relationships to Disclose
 
Romain Daillere
Employment - EverImmune
Patents, Royalties, Other Intellectual Property - EverImmune
 
Gwénaël Le Teuff
No Relationships to Disclose
 
Jean-Yves Scoazec
No Relationships to Disclose
 
Laurence Zitvogel
Leadership - EverImmune
Patents, Royalties, Other Intellectual Property - EverImmune
 
Yohann Loriot
Honoraria - Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Immunomedics; Janssen; Janssen (Inst); MSD Oncology; MSD Oncology (Inst); Roche; Seagen; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); CureVac (Inst); Exelixis (Inst); Incyte (Inst); Janssen Oncology (Inst); Medivation (Inst); MSD Oncology (Inst); Nektar (Inst); Oncogenex (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen